Glenn T Werneburg, MD, PhD

Urogynecology

Accepting New Patients

Highlights

Male

Assistant Professor, Department of Urology

Miller, A. W., Jeong, S. H., McSweeney, S., Vasavada, S. P., & Werneburg, G. T. (2026). Urinary Peptide Signatures Distinguish Overactive Bladder and are Associated with Improvement in Incontinence Following Therapy. Urology.
Werneburg, G. T., Gross, M. D., Hettel, D. R., Lyon, M., Jeong, S. H., McSweeney, S., ... & Miller, A. W. (2026). Urinary Microbiome and Metabolome Differentiate Overactive Bladder From the Physiological State, and Reflect Recent Antibiotic Use and Treatment Response. The Journal of Urology, 216(1), 78-88.
Harding, C., Da Silva, A., Khasriya, R., Khullar, V., Lombardo, R., Malde, S., ... & Werneburg, G. (2026). Is There Adequate Evidence for Intracellular Bacteria Being a Significant Cause of rUTIs and Thereby Justifying Targeted Treatments Such as Bladder Fulguration or Intravesical Therapies? ICI‐RS 2025. Neurourology and Urodynamics, 45(5), 914-921.
Cameron, A. P., & Werneburg, G. T. (2025). Foley catheter management: a review. JAMA surgery, 160(6), 701-707.
Jeong, S. H., Vasavada, S. P., Lashner, B., & Werneburg, G. T. (2025). Fecal microbiota transplant is associated with resolution of recurrent urinary tract infection. Urology.

Please contact the doctor's office directly to confirm acceptance of insurance.

Search plans

Start typing to search for insurances accepted